Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoter

Cisplatin is one of the most potent chemotherapeutic agents for the treatment of colon cancer. Nevertheless, the unavoidability of the notable toxicity and the development of the acquired resistance severely restricted its clinical application. Aspirin and some other non-steroidal anti-inflammatory...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Aging (Albany NY)
Päätekijät: Jiang, Wei, Yan, Yue, Chen, Manyu, Luo, Guangyu, Hao, Jiaojiao, Pan, Jinjin, Hu, Sheng, Guo, Ping, Li, Wenyang, Wang, Ruozu, Zuo, Yan, Sun, Yao, Sui, Silei, Yu, Wendan, Pan, Zhe, Zou, Kun, Zheng, Zongheng, Deng, Wuguo, Wu, Xiaojun, Guo, Wei
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals 2020
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6977689/
https://ncbi.nlm.nih.gov/pubmed/31905343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.102644
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia